Carsten Dehning

Carsten Dehning is Chief Financial Officer at Emergence Therapeutics and a member of the Executive Board. Joining the Emergence Therapeutics team at the founding stage, he brings to the company over 20 years’ experience serving as a Chief Executive Officer and Chief Financial Officer at a number of healthcare companies including DeveloGen, Aspireo Pharmaceuticals, Albireo, Biovertis and Bourn Hall International. Mr Dehning is regularly advising companies in the healthcare sector as well as healthcare investors. Mr Dehning holds a Diploma in business administration from the University of Göttingen, Germany.